What is UTHR's five-year median P/E?

16.3x. Half of UTHR's weekly readings over the last five years were higher and half were lower. This page has 809 weekly readings, from Apr 25, 2011 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares UTHR only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

United Therapeutics Corp (UTHR) valuation history

Health Care

$587.50

Latest weekly close · Market cap $26.9B

Historically high

As of Oct 24, 2026

UTHR's P/E of 21.0x is higher than 98% of its weekly readings over the last five years.

Weekly P/E with its 5-year range

P/E each weekMiddle half of the last 5 years5-year median 16.3×

5-year median: 16.3×
10-year median: 14.1×
5-year low to high: 11.3×–21.9×
Versus 5-year median: +29%

P/E

98thpercentile

of its weekly readings over the last five years

Historically high

Growth, last 12 months vs the year before

Revenue: +2%slowing
EPS: +9%

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

P/E at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

UTHR P/E at each year-end
Year-end	P/E	5-year percentile
Dec 29, 2025	18.8×	82
Dec 30, 2024	15.7×	51
Dec 25, 2023	12.1×	21
Dec 26, 2022	18.9×	80
Dec 27, 2021	21.9×	100
Dec 28, 2020	14.4×	96
Dec 30, 2019	n/a	Too little history
Dec 31, 2018	9.1×	24
Dec 25, 2017	13.1×	52
Dec 26, 2016	9.7×	20

Health Care peers on P/E

Each percentile compares a stock with its own last five years.

Compare UTHR with peers

Health Care peers of UTHR on P/E
Stock	P/E	Versus its own history	5-year percentile
ABBVAbbVie	80.6×	Above its usual range	76
AMGNAmgen	27.8×	Above its usual range	78
ARWRArrowhead Pharmaceuticals Inc	n/a	Not ranked	n/a, not ranked
BBIOBridgebio Pharma Inc	n/a	Not ranked	n/a, not ranked
BIIBBiogen	44.8×	Historically high	100

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on UTHR

No articles about UTHR yet. How valuation percentiles work

Loading peers and related research…

About this history

What is UTHR's current P/E?: UTHR's P/E of 21.0x is higher than 98% of its weekly readings over the last five years.
What is UTHR's five-year median P/E?: 16.3x. Half of UTHR's weekly readings over the last five years were higher and half were lower. This page has 809 weekly readings, from Apr 25, 2011 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares UTHR only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.